Extreme body mass index and survival in newly diagnosed multiple myeloma patients

被引：8

作者：

Shah, Urvi A. A. ^{[1
,2
]}

Whiting, Karissa ^{[3
]}

Devlin, Sean ^{[3
]}

Ershler, Rachel ^{[4
]}

Kanapuru, Bindu ^{[4
]}

Lee, David J. J. ^{[5
,6
]}

Tahri, Sabrin ^{[6
,7
]}

Gwise, Thomas ^{[8
]}

Rustad, Even H. H. ^{[9
,10
]}

Mailankody, Sham ^{[1
,2
]}

Lesokhin, Alexander M. M. ^{[1
,2
]}

Kazandjian, Dickran ^{[11
]}

Maura, Francesco ^{[11
]}

Auclair, Daniel ^{[12
]}

Birmann, Brenda M. M. ^{[13
,14
]}

Usmani, Saad Z. Z. ^{[1
,2
]}

Gormley, Nicole ^{[4
]}

Marinac, Catherine R. R. ^{[6
]}

Landgren, Ola ^{[11
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10065 USA

[2] Weill Cornell Med Coll, Dept Med, 400 East 67th St, New York, NY 10065 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10065 USA

[4] US FDA, Ctr Drug Evaluat & Res, Div Hematol Malignancies 2, 5901-B Ammendale Rd, Beltsville, MD 20705 USA

[5] Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA

[7] Erasmus Univ, Dept Hematol, Med Ctr, NL-3000 CA Rotterdam, Netherlands

[8] US FDA, Ctr Drug Evaluat & Res, Div Biometr 9, 5901-B Ammendale Rd, Beltsville, MD 20705 USA

[9] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Canc Immunol, N-0379 Oslo, Norway

[10] Lovisenberg Diaconal Hosp, Dept Med, 25 Shattuck St, N-0456 Boston, MA, Norway

[11] Sylvester Comprehens Canc Ctr Univ Miami, Dept Med, 1475 NW 12th Ave, Miami, FL 33136 USA

[12] Multiple Myeloma Res Fdn, 383 Main Ave 5, Norwalk, CT 06851 USA

[13] Harvard Med Sch, 181 Longwood Ave, Boston, MA 02115 USA

[14] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA

来源：

BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期

基金：

美国国家卫生研究院;

关键词：

OBESITY PARADOX; CANCER; RISK;

D O I：

10.1038/s41408-022-00782-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[21] Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma
Nakamura, S.
Miki, H.
Okamoto, Y.
Sogabe, K.
Oura, M.
Takahashi, M.
Iwasa, M.
Harada, T.
Fujii, S.
Kagawa, K.
Abe, M.
ANNALS OF ONCOLOGY, 2018, 29
[22] Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma
Thirugnanasambandam, Ram Prakash
Firestone, Ross
Derkach, Andriy
Maclachlan, Kylee
Hultcrantz, Malin
Mailankody, Sham
Lahoud, Oscar
Landau, Heather
Chung, David
Shah, Gunjan
Scordo, Michael
Hassoun, Hani
Lesokhin, Alexander
Giralt, Sergio
Korde, Neha
Usmani, Saad
Tan, Carlyn Rose
Shah, Urvi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S307 - S308
[23] Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma
Mellors, Patrick
Binder, Moritz
Buadi, Francis K.
Lacy, Martha Q.
Gertz, Morie A.
Dispenzieri, Angela
Hayman, Suzanne R.
Kapoor, Prashant
Gonsalves, Wilson I.
Hwa, Yi
Fonder, Amie
Hobbs, Miriam
Kourelis, Taxiarchis
Warsame, Rahma
Zeldenrust, Steven
Lust, John A.
Leung, Nelson
Go, Ronald S.
Kyle, Robert A.
Rajkumar, S. Vincent
Kumar, Shaji K.
BLOOD, 2018, 132
[24] Time to plateau as a predictor of survival in newly diagnosed multiple myeloma
Mellors, Patrick W.
Binder, Moritz
Buadi, Francis K.
Lacy, Martha Q.
Gertz, Morie A.
Dispenzieri, Angela
Hayman, Suzanne R.
Kapoor, Prashant
Gonsalves, Wilson I.
Hwa, Yi L.
Fonder, Amie
Hobbs, Miriam
Kourelis, Taxiarchis
Warsame, Rahma
Zeldenrust, Steven R.
Lust, John A.
Leung, Nelson
Go, Ronald S.
Kyle, Robert A.
Rajkumar, S. Vincent
Kumar, Shaji K.
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 889 - 894
[25] Differences in Presentation and Survival Outcomes for African American Patients with Newly Diagnosed Multiple Myeloma
Joseph, Nisha
Gupta, Vikas A.
Hofmeister, Craig C.
Gleason, Charise
Heffner, Leonard
Boise, Lawrence H.
Kaufman, Jonathan L.
Dhodapkar, Madhav V.
Lonialand, Sagar
Nooka, Ajay K.
BLOOD, 2018, 132
[26] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
W I Gonsalves
N Leung
S V Rajkumar
A Dispenzieri
M Q Lacy
S R Hayman
F K Buadi
D Dingli
P Kapoor
R S Go
Y Lin
S J Russell
J A Lust
S Zeldenrust
R A Kyle
M A Gertz
S K Kumar
Blood Cancer Journal, 2015, 5 : e296 - e296
[27] Improvement in Renal Function and Its Impact on Survival in Patients with Newly Diagnosed Multiple Myeloma
Gonsalves, Wilson I.
Leung, Nelson
Rajkumar, S. Vincent
Dispenzieri, Angela
Buadi, Francis
Lacy, Martha Q.
Dingli, David
Kapoor, Prashant
Go, Ronald S.
Lust, John A.
Hayman, Suzanne R.
Lin, Yi
Zeldenrust, Steven R.
Kyle, Robert A.
Gertz, Morie A.
Kumar, Shaji
BLOOD, 2014, 124 (21)
[28] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
Gonsalves, W. I.
Leung, N.
Rajkumar, S. V.
Dispenzieri, A.
Lacy, M. Q.
Hayman, S. R.
Buadi, F. K.
Dingli, D.
Kapoor, P.
Go, R. S.
Lin, Y.
Russell, S. J.
Lust, J. A.
Zeldenrust, S.
Kyle, R. A.
Gertz, M. A.
Kumar, S. K.
BLOOD CANCER JOURNAL, 2015, 5 : e296 - e296
[29] The Reversal of Renal Impairment and its Impact on Survival in Newly Diagnosed Multiple Myeloma Patients
Gonsalves, Wilson I.
Leung, Nelson
Rajkumar, S. Vincent
Dispenzieri, Angela
Buadi, Francis K.
Lacy, Martha Q.
Dingli, David
Kapoor, Prashant
Lust, John A.
Go, Ronald S.
Hayman, Suzanne R.
Lin, Yi
Zeldenrust, Steven
Kyle, Robert A.
Gertz, Morie A.
Kumar, Shaji K.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S239 - S239
[30] Differences in presentation and survival outcomes for African American patients with newly diagnosed multiple myeloma
Joseph, Nisha
Gupta, Vikas A.
Hofmeister, Craig
Gleason, Charise
Heffner, Leonard T.
Jonathan, Kafuman L.
Boise, Lawrence H.
Dhodapkar, Madhav D.
Lonial, Sagar
Nooka, Ajay K.
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →